Researchers at the University of Central Florida identified a cow-derived antimicrobial peptide that destroys drug-resistant Klebsiella pneumoniae biofilms [1].
This discovery provides a potential pathway to treat infections that are otherwise impervious to standard antibiotics. Bacterial biofilms act as protective shields, making it difficult for medicine to reach the pathogens inside.
Assistant Professor Renee Fleeman and her team at the UCF College of Medicine led the study [1]. The research focused on the ability of this specific peptide, naturally found in cows, to weaken and dismantle the biofilm structure [2]. Once the protective layer is breached, the peptide can kill the drug-resistant bacteria [1].
Klebsiella pneumoniae is known for its ability to cause severe infections in humans and animals. Because these bacteria can develop resistance to multiple drugs, finding a way to penetrate their physical defenses is a critical goal for medical science [2].
The team developed this therapy to combat infections that are increasingly difficult to treat with traditional pharmaceutical interventions [1]. By utilizing a naturally occurring peptide, the researchers aim to create a treatment that can effectively penetrate these biofilms, and eliminate the underlying bacteria [2].
The findings were released this month, marking a significant step in the development of new antimicrobial strategies [1]. The research underscores the potential of animal-derived peptides to solve human health challenges related to antibiotic resistance [2].
“A cow-derived antimicrobial peptide that destroys drug-resistant Klebsiella pneumoniae biofilms.”
The ability to dismantle biofilms represents a shift from trying to overpower bacteria with stronger chemicals to removing the physical barriers that protect them. If this peptide can be successfully transitioned into a human therapy, it could reduce the reliance on high-dose antibiotics and provide a new tool against the growing threat of antimicrobial resistance.
